Form 8.5 (EPT/RI) – Alliance Pharma plc | Taiwan News | Jan. 20, 2025 16:39
Public Dealing Disclosure by an Exempt Principal Trader
This disclosure is made under Rule 8.5 of the Takeover Code.
1. Key Information
(a) Name of exempt principal trader: Investec Bank plc
(b) Name of offeror/offeree: Alliance Pharma plc
(c) Name of the party to the offer with which the exempt principal trader is connected: Investec is the financial advisor to Aegros Bidco Limited, a newly incorporated company indirectly owned by DBAY Affiliates and the ERES IV Fund.
(d) Date dealing undertaken: 17th January 2025
(e) In addition to the company mentioned in (b), is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A”: N/A
2. Dealings by the Exempt Principal Trader
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), please find the details below:
(a) Purchases and Sales
| Class of Relevant Security | Action | Total Number of Securities | Highest Price per Unit Paid/Received | Lowest Price per Unit Paid/Received |
|---|---|---|---|---|
| Ordinary shares | Purchases | 23,807 | 61.1 | 60.9 |
| Ordinary shares | Sales | 5,848 | 61.3 | 61.3 |
(b) Cash-settled Derivative Transactions
No cash-settled derivative transactions to report.
(c) Stock-settled Derivative Transactions (including options)
(i) Writing, Selling, Purchasing or Varying
No relevant stock-settled derivative transactions reported.
(ii) Exercise
No exercises of stock-settled derivatives reported.
(d) Other Dealings (Including Subscribing for New Securities)
No other dealings are applicable.
3. Other Information
(a) Indemnity and Other Dealing Arrangements
No indemnity or option arrangement has been entered into by the exempt principal trader that may be an inducement to deal or refrain from dealing.
(b) Agreements, Arrangements or Understandings Relating to Options or Derivatives
No agreements, arrangements, or understandings in relation to voting rights or future acquisition or disposal of any relevant securities are reported.
Date of disclosure: 20th January 2025
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
